Preparation with iopanoic acid rapidly controls thyrotoxicosis in patients with amiodarone-induced thyrotoxicosis before thyroidectomy

Surgery

Volumn 132, Issue 6, 2002, Pages 1114-1118

  Bogazzi, Fausto ^a,b,c   Miccoli, Paolo ^a,b,c   Berti, Piero ^a,b,c   Cosci, Chiara ^a,b,c   Brogioni, Sandra ^a,b,c   Aghini Lombardi, Fabrizio ^a,b,c   Materazzi, Gabriele ^a,b,c   Bartalena, Luigi ^a,b,c   Pinchera, Aldo ^a,b,c   Braverman, Lewis E ^a,b,c   Martino, Enio ^a,b,c   Gough, Ian ^d   Thompson, Geoffrey B ^d   Beazley, Robert M ^d   Carter, W Bradford ^d  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c BOSTON MEDICAL CENTER   (United States)

^d Ospedale di Cisanello ^*

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; IOPANOIC ACID; LIOTHYRONINE; PARATHYROID HORMONE; THYROGLOBULIN ANTIBODY; THYROID HORMONE; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HEART ARRHYTHMIA; HUMAN; IMMUNORADIOMETRIC ASSAY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; THYROID DISEASE; THYROID HORMONE BLOOD LEVEL; THYROID SURGERY; THYROID WEIGHT; THYROIDECTOMY; THYROTOXICOSIS; TREATMENT OUTCOME;

EID: 0036915109     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2002.128561     Document Type: Article

References (26)

1. Reiffel JA, Estes NA III, Waldo AL, Prystowsky EN, Di Bianco R. A consensus report on antiarrhythmic drug use. Clin Cardiol 1994;17:103-16.
2. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R. Randomized trial of low-dose amiodarone in severe congestive heart failure. Lancet 1994;344:493-8.
3. Martino E, Bartalena L, Bogazzi F, Braverman LE. Amiodarone and the thyroid. Endocr Rev 2001;22:240-54.
4. Bartalena L, Bogazzi F, Braverman LE, Martino E. Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment. J Endocrinol Invest 2001;24:116-30.
5. Bartalena L, Brogioni S, Grasso L, Bogazzi F, Burelli A, Martino E. Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: Results from a prospective study. J Clin Endocrinol Metab 1996;81:2930-3.
6. Brennan MD, van Heerden JA, Carney JA. Amiodarone-associated thyrotoxicosis (AAT): Experience with surgical management. Surgery 1987;102:1062-7.
7. Farwell AP, Abend SL, Huang SK, Patwardhan NA, Braverman LE. Thyroidectomy for amiodarone-induced thyrotoxicosis. JAMA 1990;263:1526-8.
8. Mulligan DC, McHenry CR, Kinney W, Esselstyn CB Jr. Amiodarone-induced thyrotoxicosis: Clinical presentation and expanded indications for thyroidectomy. Surgery 1993;114:1114-9.
9. Claxton S, Sinha SN, Donovan S, Greenaway TM, Hoffman L, Loughhead M, et al. Refractory, amiodarone-associated thyrotoxicosis: An indication to thyroidectomy. Aust N Z J Surg 2000;70:155-6.
10. Burgi H, Winpfheimer C, Buerger A, Zaunbauer W, Rosler H, Lemarchand-Beraud T. Changes of circulating thyroxine, triiodothyronine, and reverse triiodothyronine after radiocontrast agents. J Clin Endocrinol Metab 1976;43:1203-10.
11. Wu SY, Chopra IJ, Solomon DH, Bennett LR. Changes in circulating iodothyronines in euthyroid and hyperthyroid subjects given ipodate (Oragrafin), an agent for oral cholecystography. J Clin Endocrinol Metab 1978;46:691-7.
12. Braga M, Cooper DS. Oral cholecystographic agents and the thyroid. J Clin Endocrinol Metab 2001;86:1853-60.
13. Wang Y, Tsou C, Lin W, Hershman J. Long-term treatment of Graves' disease with iopanoic acid (Telepaque). J Clin Endocrinol Metab 1987;65:679-82.
14. Martino E, Balzano S, Bartalena L, Loviselli A, Sica V, Petrini L, et al. Therapy of Graves' disease with sodium ipodate is associated with a high recurrence rate of hyperthyroidsm. J Endocrinol Invest 1991;14:847-51.
15. Bogazzi F, Aghini-Lombardi F, Cosci C, Lupi I, Santini F, Tanda ML, et al. Iopanoic acid rapidly controls type I amiodarone-induced thyrotoxicosis prior to thyrodectomy. J Endocrinol Invest 2002;25:176-9.
16. Bogazzi F, Bartalena L, Brogioni S, Mazzeo S, Vitti P, Burelli A, et al. Color flow doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. Thyroid 1997;7:541-5.
17. Trip MD, Wiersinga W. Incidence, predictability, and patho-genesis of amiodarone-induced thyrotoxicosis and hypothyroidism. Am J Med 1991;91:507-11.
18. Martino E, Aghini-Lombardi F, Bartalena L, Grasso L, Loviselli A, Velluzzi F, et al. Enhanced susceptibility to amiodarone-induced hypothyroidism in patients with thyroid atttoimmune disease. Arch Intern Med 1994;154:2722-6.
19. Martino E, Safran M, Aghini-Lombardi F, Rajatanavin R, Lenziardi M, Fay M, et al. Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann Intern Med 1984;101:28-34.
20. Chiovato L, Martino E, Tonacchera M, Santini F, Lapi P, Mammoli C, et al. A. Studies on the in vitro cytotoxic effect of amiodarone. Endocrinology 1994;134:2277-82.
21. Di Matola T, D'Ascoli F, Fenzi G, Rossi G, Martino E, Bogazzi F, et al. Amiodarone induces cytochrome c release and apoptosis through an iodine-independent mechanism. J Clin Endocrinol Metab 2000;85:4323-30.
22. Eaton SEM, Euinton HA, Newman CM, Weetman AP, Bennet WM. Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: Role of colour-flow doppler sonography. Clin Endocrinol (Oxf) 2002;56:33-8.
23. Bartalena L, Bogazzi F, Martino E. Amiodarone-induced thyrotoxicosis: A difficult dignostic and therapeutic challenge. Clin Endocrinol 2002;56:23-4.
24. Aghini-Lombardi F, Mariotti S, Fosella PV, Grasso L, Pinchera A, Braverman LE, et al. Treatment of amiodarone iodine-induced thyrotoxicosis with plasmapheresis and methimazole. J Endocrinol Invest 1993;16:823-6.
25. Baeza A, Aguayo J, Barria M, Pineta G. Rapid preoperative preparation in hyperthyroidism. Clin Endocrinol 1991;35:439-42.
26. Chopra IJ, Baber K. Use of oral cholecystographic agents in the treatment of amiodarone induced hyperthyroidism. J Clin Endocrinol Metab 2001;86:4707-10.